Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Eigenbrot

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
Journal of Computer-Aided Molecular Design|February 14, 2019
Water molecules in protein-ligand interfaces. Evaluation of software tools and SAR comparisonEva Nittinger, Paul Gibbons, Charles Eigenbrot, et al.
The Journal of Biological Chemistry|November 15, 2013
Identification of a small peptide that inhibits PCSK9 protein binding to the low density lipoprotein receptorYingnan Zhang, Charles Eigenbrot, Lijuan Zhou, et al.
Molecular Cell|October 7, 2003
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptorsAntony W Burgess, Hyun-Soo Cho, Charles Eigenbrot, et al.
Proteins|December 1, 2010
A new regulatory switch in a JAK protein kinaseVickie Tsui, Paul Gibbons, Mark Ultsch, et al.
The Biochemical Journal|September 20, 2015
The trimeric serine protease HtrA1 forms a cage-like inhibition complex with an anti-HtrA1 antibodyClaudio Ciferri, Michael T Lipari, Wei-Ching Liang, et al.
Mabs|December 18, 2014
Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule chargeBing Li, Devin Tesar, C Andrew Boswell, et al.
Journal of Molecular Biology|January 2, 2007
Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage libraryWei-Ching Liang, Mark S Dennis, Scott Stawicki, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2014
Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479Kirk D Robarge, Wendy Lee, Charles Eigenbrot, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2014
Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitorsRichard M Pastor, Jason D Burch, Steven Magnuson, et al.
Scientific Reports|December 21, 2016
Structure of Crenezumab Complex with Aβ Shows Loss of β-HairpinMark Ultsch, Bing Li, Till Maurer, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Journal of Computer-Aided Molecular Design|February 14, 2019
Water molecules in protein-ligand interfaces. Evaluation of software tools and SAR comparisonEva Nittinger, Paul Gibbons, Charles Eigenbrot, et al.
The Journal of Biological Chemistry|November 15, 2013
Identification of a small peptide that inhibits PCSK9 protein binding to the low density lipoprotein receptorYingnan Zhang, Charles Eigenbrot, Lijuan Zhou, et al.
Molecular Cell|October 7, 2003
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptorsAntony W Burgess, Hyun-Soo Cho, Charles Eigenbrot, et al.
Proteins|December 1, 2010
A new regulatory switch in a JAK protein kinaseVickie Tsui, Paul Gibbons, Mark Ultsch, et al.
The Biochemical Journal|September 20, 2015
The trimeric serine protease HtrA1 forms a cage-like inhibition complex with an anti-HtrA1 antibodyClaudio Ciferri, Michael T Lipari, Wei-Ching Liang, et al.
Mabs|December 18, 2014
Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule chargeBing Li, Devin Tesar, C Andrew Boswell, et al.
Journal of Molecular Biology|January 2, 2007
Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage libraryWei-Ching Liang, Mark S Dennis, Scott Stawicki, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2014
Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479Kirk D Robarge, Wendy Lee, Charles Eigenbrot, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2014
Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitorsRichard M Pastor, Jason D Burch, Steven Magnuson, et al.
Scientific Reports|December 21, 2016
Structure of Crenezumab Complex with Aβ Shows Loss of β-HairpinMark Ultsch, Bing Li, Till Maurer, et al.
Pageof 11